Navigation Links
New Treatment for Parkinson's Disease Gait Presented at the American Acadamy of Neurology Annual Meeting
Date:1/25/2010

A new, in-home training device with virtual reality cues improving gait and balance in patients with Parkinson's disease was presented by lead researcher Dr. Alberto Espay at the American Acadamy of Neurology annual meeting.

(PRWEB) January 25, 2010 -- Quality of life and motor function are impaired by shuffling and freezing of gait in people with Parkinson's disease (PD).

It is well known that certain auditory and visual cues can improve motor function in people with PD.

Dr. Alberto Espay, presented the results of his study which showed successful treatment of gait impairment for Parkinson's disease by using a new patented device, the GaitAid.

Patients in the study received the device for in-home use during a two week period. The participants used the device daily for 20 minutes. Gait parameters were measured before, during and after the two week period.

Over 70% of patients in this study improved their gait.

Dr. Espay concluded his presentation: "Gait velocity and stride length were improved in PD patients with a marked residual (lasting) effect.".

During his platform presentation, Dr. Espay acknowleged this device as a "desirable, non-pharmacologic, intervention to improve walking in PD.", noting that the device is low cost, easy to use (no training by professionals is needed to use the device at home ) and it provides improved functioning by the patient during and after use.

The devices used in this study are registered with the FDA as the GaitAid device and are available for a one month trial period to individuals, clinicians, and retirement homes at the company's website: www.medigait.com

More information about the GaitAid device as well as clinical trials is available on MediGait's website.

About Dr. Espay:
Dr. Alberto Espay completed his Neurology training at Indiana University, where he was awarded the Alexander Treloar Ross Award Honorable Mention for the most outstanding paper by a neurology resident. He trained in Movement Disorders at the Toronto Western Hospital, with Dr. Anthony Lang, during 2001-2003. He then completed a Dystonia Medical Research Foundation Clinical Research Fellowship with special training in Electrophysiology of Movement Disorders, with Dr. Robert Chen, and a thesis-based MSc Graduate program in Clinical Epidemiology and Health Care Research at the University of Toronto, both during 2003-2005. Dr. Espay received a two-year Sam and Fran Belzberg and Dennis and Barbara Kessler DMRF award for his study “Pathophysiology of Psychogenic Dystonia,” published by the Annals of Neurology in 2006. He has published 27 peer-reviewed articles and has authored 6 book chapters and 24 published abstracts and presented papers.  Dr. Espay has been awarded the Dean’s Scholar in Clinical Research Award by the University of Cincinnati for the years 06/07, 07/08, and 08/09 which “fosters the career development of promising junior faculty in clinical research.” Dr. Espay is the principal investigator in four ongoing investigator-initiated clinical studies at the University of Cincinnati, including a clinical trial sponsored by the Michael J. Fox Foundation, evaluating the effects of methylphenidate on the freezing of gait in patients with Parkinson’s disease. He serves as a member of the Institutional Research Board at the University of Cincinnati and is an ad hoc reviewer for 13 neurology and medical journals. Dr. Espay is the founder and director of the Toronto Western Extended Research Network, a community of movement disorders neurologists designing and developing common clinical research protocols. He has been an Assistant Professor of Neurology at the University of Cincinnati since July 2005.

About the GaitAid and MediGait:
The idea for the GaitAid project was sparked 12 years ago while Professor Baram was designing a mechanism for NASA to navigate low-flying helicopters around obstacles. The concept of the design, which Baram later applied to the medical device, is that the optical images of objects help the observer navigate, stabilize and pace movement in space.

###

Read the full story at http://www.prweb.com/releases/2010/01/prweb3513564.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. New treatment effective in counteracting cocaine-induced symptoms
2. New treatment boosts muscle function in myasthenia gravis
3. Broad-based group of physicians calls for improvement in stroke treatment
4. Cranberry Could Juice Up Ovarian Cancer Treatment
5. Non-medicinal treatment touted for pre-schoolers with ADHD
6. Nonmedicinal treatment touted for preschoolers with ADHD
7. U of M study: Early treatment can reverse heart damage
8. Biologic treatment for rheumatoid arthritis and the risk of cancer
9. New Treatment Explored for Cluster Headaches
10. Thailand: Partners Open Free AIDS Treatment Clinic in Renowned AIDS Temple in Lop Buri
11. 4-Star Gen. Barry Mccaffrey, Former U.S. Drug Czar, to Keynote Recovery Happens! Rally for Treatment: Wed., Sept. 5, 11 Am, State Capitol West Steps, Sacramento
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Treatment for Parkinson's Disease Gait Presented at the American Acadamy of Neurology Annual Meeting
(Date:3/24/2017)... ... March 24, 2017 , ... Empower Brokerage, located in Southlake, ... leads programs. , In February, 2017, Empower Brokerage introduced their new “Performance Partners” ... designed to teach how to maximize their sales efforts, as well as how ...
(Date:3/24/2017)... ... March 24, 2017 , ... “Vintage and Harvest A Cultivation of ... college Bible teacher residing in North Carolina with his wife, Anna Marie. He and ... with six grandchildren. David is also the author of “Shadow and Substance.” , “Love, ...
(Date:3/23/2017)... ... March 23, 2017 , ... A recent report from the National Council ... programs. The NCTQ report suggests, based on a review of GPA and SAT/ACT requirements ... quality in the U.S. It argues that this higher bar should be set by ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... Center at 10 North Broadway Avenue, will be an educational and exciting program ... instruction in the management of chronic pain. , Oklahoma is in a healthcare ...
(Date:3/23/2017)... (PRWEB) , ... March 23, ... ... and financial services firm serving the families and businesses of the Norwalk ... enrichment program. Northern Ohio Recovery Center (N.O.R.A.) is a nonprofit, community-based substance ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... , Mar. 24, 2017 Research ... Management in the U.S.: Consumer Strategies" report to their ... ... how adults approach and treat their physical pain, emphasizing consumer ... distinct groups: pain sufferers and adults who have selected illnesses/conditions ...
(Date:3/24/2017)... SHANGHAI , March 24, 2017 /PRNewswire/ ... organization providing high-quality and cost-effective drug development ... the pharmaceutical and biotechnology industry, announced today ... ShangPharma will be consolidating the ... Organizations (CMO) under Shanghai ChemPartner. These entities ...
(Date:3/24/2017)... -- Research and Markets has announced the addition of the ... their offering. ... pipeline is very strong with a total of 97 drug candidates. Pharma ... Sanofi are involved in the development of the IPF therapeutics. The IPF ... III stage, 15 are in Phase II stage, 12 are in Phase ...
Breaking Medicine Technology: